-
The European Medicines Agency, EMEA, concludes its formal validation of the marketing authorization application for Theraloc® (Nimotuzumab) positively
Oncoscience | October 26th, 2007
The application for marketing authorization of Theraloc® (Nimotuzumab) was submitted to EMEA on October 4th, 2007. Aft...
-
Oncoscience AG reports marketing authorization approval for Theraloc® (Nimotuzumab) in the Ukraine
Oncoscience | October 13th, 2007
On October 12th, 2007 Theraloc® was approved in the Ukraine by the Ministry of Health of Ukraine. As of now Theraloc®...
